BackgroundEndothelial cells (ECs) form blood vessels through angiogenesis that is regulated by coordination of vascular endothelial growth factor (VEGF), Notch, transforming growth factor β, and other signals, but the detailed molecular mechanisms remain unclear.Methods and ResultsSmall RNA sequencing initially identified miRâ342â5p as a novel downstream molecule of Notch signaling in ECs. Reporter assay, quantitative reverse transcription polymerase chain reaction and Western blot analysis indicated that miRâ342â5p targeted endoglin and modulated transforming growth factor β signaling by repressing SMAD1/5 phosphorylation in ECs. Transfection of miRâ342â5p inhibited EC proliferation and lumen formation and reduced angiogenesis in vitro and in vivo, as assayed by using a fibrin beadsâbased sprouting assay, mouse aortic ring culture, and intravitreal injection of miRâ342â5p agomir in P3 pups. Moreover, miRâ342â5p promoted the migration of ECs, accompanied by reduced endothelial markers and increased mesenchymal markers, indicative of increased endothelialâmesenchymal transition. Transfection of endoglin at least partially reversed endothelialâmesenchymal transition induced by miRâ342â5p. The expression of miRâ342â5p was upregulated by transforming growth factor β, and inhibition of miRâ342â5p attenuated the inhibitory effects of transforming growth factor β on lumen formation and sprouting by ECs. In addition, VEGF repressed miRâ342â5p expression, and transfection of miRâ342â5p repressed VEGFR2 and VEGFR3 expression and VEGFâtriggered Akt phosphorylation in ECs. miRâ342â5p repressed angiogenesis in a laserâinduced choroidal neovascularization model in mice, highlighting its clinical potential.ConclusionsmiRâ342â5p acts as a multifunctional angiogenic repressor mediating the effects and interaction among angiogenic pathways.